Changchun BCHT Biotechnology Co. (SHA:688276)

China flag China · Delayed Price · Currency is CNY
14.54
+0.05 (0.35%)
Jun 12, 2026, 3:00 PM CST
Market Cap6.01B -30.3%
Revenue (ttm)590.13M -47.4%
Net Income-267.12M
EPS-0.65
Shares Out 413.66M
PE Ration/a
Forward PEn/a
Dividend0.17 (1.16%)
Ex-Dividend DateJun 18, 2025
Volume2,913,247
Open14.50
Previous Close14.49
Day's Range14.29 - 14.73
52-Week Range14.20 - 26.30
Beta0.09
AnalystsStrong Buy
Price Target32.00 (+120.08%)
Earnings DateAug 18, 2026

About SHA:688276

Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company’s products include herpes zoster vaccine; varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China. [Read more]

Sector Healthcare
Founded 2004
Employees 1,252
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688276
Full Company Profile

Financial Performance

Financial Statements